Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Liana Moussatos's Stock Ratings
Wedbush Analyst
Liana Moussatos is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/29/2025
Overall Average Return
44.2%
Smart Score
Overall Average Return Percentile
93rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $0.85 | 371.7% | Liana Moussatos77% | $5 → $4 | Maintains | Outperform | Get Alert |
| 03/01/2024 | VRNA | Buy Now | Verona Pharma | $73.58 | -55.15% | Liana Moussatos77% | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 02/22/2024 | UTHR | Buy Now | United Therapeutics | $300.76 | 2.41% | Liana Moussatos77% | $308 → $308 | Reiterates | Outperform → Outperform | Get Alert |
| 11/02/2023 | UTHR | Buy Now | United Therapeutics | $300.76 | 2.41% | Liana Moussatos77% | $307 → $308 | Maintains | Outperform | Get Alert |
| 08/03/2023 | UTHR | Buy Now | United Therapeutics | $300.76 | 2.07% | Liana Moussatos77% | $305 → $307 | Maintains | Outperform | Get Alert |
| 06/28/2023 | VRNA | Buy Now | Verona Pharma | $73.58 | -59.23% | Liana Moussatos77% | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $89.00 | -15.73% | Liana Moussatos77% | → $75 | Reiterates | Outperform → Outperform | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $89.00 | 19.1% | Liana Moussatos77% | $120 → $106 | Maintains | Outperform | Get Alert |
| 09/01/2022 | LQDA | Buy Now | Liquidia | $13.41 | -77.63% | Liana Moussatos77% | $4 → $3 | Downgrade | Neutral → Underperform | Get Alert |
| 06/17/2022 | VRNA | Buy Now | Verona Pharma | $73.58 | -75.54% | Liana Moussatos77% | $25 → $18 | Maintains | Outperform | Get Alert |
| 05/24/2022 | UTHR | Buy Now | United Therapeutics | $300.76 | -12.55% | Liana Moussatos77% | $236 → $263 | Maintains | Outperform | Get Alert |
| 03/03/2022 | ASND | Buy Now | Ascendis Pharma | $166.00 | -29.52% | Liana Moussatos77% | $128 → $117 | Maintains | Outperform | Get Alert |
| 02/28/2022 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 248.15% | Liana Moussatos77% | $97 → $94 | Maintains | Outperform | Get Alert |
| 02/28/2022 | UTHR | Buy Now | United Therapeutics | $300.76 | -21.53% | Liana Moussatos77% | $276 → $236 | Maintains | Outperform | Get Alert |
| 09/16/2021 | ALBO | Buy Now | Albireo Pharma | — | — | Liana Moussatos77% | $82 → $84 | Maintains | Outperform | Get Alert |
| 09/07/2021 | XOMA | Buy Now | XOMA | $24.38 | -9.76% | Liana Moussatos77% | → $22 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2021 | AVTE | Buy Now | Aerovate Therapeutics | $2.65 | 767.76% | Liana Moussatos77% | → $805 | Initiates | → Outperform | Get Alert |
| 07/21/2021 | ALBO | Buy Now | Albireo Pharma | — | — | Liana Moussatos77% | $73 → $82 | Maintains | Outperform | Get Alert |
| 06/17/2021 | BPMC | Buy Now | Blueprint Medicines | $89.00 | 46.07% | Liana Moussatos77% | $136 → $130 | Maintains | Outperform | Get Alert |
| 06/17/2021 | CLSD | Buy Now | Clearside Biomedical | $0.85 | 2022.64% | Liana Moussatos77% | $6 → $18 | Maintains | Outperform | Get Alert |
| 06/14/2021 | ASND | Buy Now | Ascendis Pharma | $166.00 | 13.86% | Liana Moussatos77% | $219 → $189 | Maintains | Outperform | Get Alert |
| 04/13/2021 | BPMC | Buy Now | Blueprint Medicines | $89.00 | 52.81% | Liana Moussatos77% | $119 → $136 | Maintains | Outperform | Get Alert |
| 03/10/2021 | GRAY | Buy Now | Graybug Vision | — | — | Liana Moussatos77% | $574 → $112 | Downgrade | Outperform → Neutral | Get Alert |
| 03/01/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | $106 → $88 | Maintains | Outperform | Get Alert |
| 01/29/2021 | LXRX | Buy Now | Lexicon Pharmaceuticals | $0.67 | 1097.96% | Liana Moussatos77% | $2 → $8 | Downgrade | Outperform → Neutral | Get Alert |
| 11/20/2020 | LQDA | Buy Now | Liquidia | $13.41 | -70.17% | Liana Moussatos77% | $20 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 11/02/2020 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 207.41% | Liana Moussatos77% | $85 → $83 | Maintains | Outperform | Get Alert |
| 11/02/2020 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Liana Moussatos77% | → $6.9 | Downgrade | Outperform → Neutral | Get Alert |
| 10/20/2020 | GRAY | Buy Now | Graybug Vision | — | — | Liana Moussatos77% | → $574 | Initiates | → Outperform | Get Alert |
| 09/01/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Liana Moussatos77% | $66 → $34.5 | Downgrade | Outperform → Neutral | Get Alert |
| 07/30/2020 | UTHR | Buy Now | United Therapeutics | $300.76 | -18.87% | Liana Moussatos77% | $243 → $244 | Maintains | Outperform | Get Alert |
| 06/05/2020 | IMUX | Buy Now | Immunic | $1.41 | 4084.4% | Liana Moussatos77% | → $59 | Initiates | → Outperform | Get Alert |
| 05/28/2020 | AXLA | Buy Now | Axcella Health | — | — | Liana Moussatos77% | → $700 | Initiates | → Outperform | Get Alert |
| 04/21/2020 | VRNA | Buy Now | Verona Pharma | $73.58 | -32.05% | Liana Moussatos77% | $60 → $50 | Maintains | Outperform | Get Alert |
| 04/03/2020 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | Liana Moussatos77% | $1050 → $990 | Maintains | Outperform | Get Alert |
| 03/03/2020 | ALBO | Buy Now | Albireo Pharma | — | — | Liana Moussatos77% | $69 → $60 | Maintains | Outperform | Get Alert |
| 03/02/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | 158.35% | Liana Moussatos77% | $175 → $164 | Maintains | Outperform | Get Alert |
| 02/10/2020 | AQST | Buy Now | Aquestive Therapeutics | $2.85 | 1163.16% | Liana Moussatos77% | $35 → $36 | Maintains | Outperform | Get Alert |
| 01/27/2020 | CLSD | Buy Now | Clearside Biomedical | $0.85 | 489.62% | Liana Moussatos77% | $3 → $5 | Maintains | Outperform | Get Alert |
| 12/26/2019 | LQDA | Buy Now | Liquidia | $13.41 | 175.92% | Liana Moussatos77% | $50 → $37 | Maintains | Outperform | Get Alert |
| 12/17/2019 | AQST | Buy Now | Aquestive Therapeutics | $2.85 | 1092.98% | Liana Moussatos77% | $37 → $34 | Maintains | Outperform | Get Alert |
| 10/25/2019 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | 139.45% | Liana Moussatos77% | $128 → $152 | Maintains | Outperform | Get Alert |
| 10/22/2019 | ASND | Buy Now | Ascendis Pharma | $166.00 | 12.05% | Liana Moussatos77% | $191 → $186 | Maintains | Outperform | Get Alert |
| 06/03/2019 | ASND | Buy Now | Ascendis Pharma | $166.00 | 34.34% | Liana Moussatos77% | $219 → $223 | Maintains | Outperform | Get Alert |
| 05/02/2019 | UTHR | Buy Now | United Therapeutics | $300.76 | -9.23% | Liana Moussatos77% | $269 → $273 | Maintains | Outperform | Get Alert |
| 04/26/2019 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | 101.64% | Liana Moussatos77% | $127 → $128 | Maintains | Outperform | Get Alert |
| 03/05/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | Liana Moussatos77% | $91 → $95 | Maintains | Outperform | Get Alert |
| 02/19/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | $220 → $248 | Maintains | Outperform | Get Alert |
| 12/06/2018 | AQST | Buy Now | Aquestive Therapeutics | $2.85 | 952.63% | Liana Moussatos77% | $29 → $30 | Maintains | Outperform | Get Alert |
| 11/01/2018 | LQDA | Buy Now | Liquidia | $13.41 | 108.81% | Liana Moussatos77% | $26 → $28 | Maintains | Outperform | Get Alert |
| 09/13/2018 | AQST | Buy Now | Aquestive Therapeutics | $2.85 | 1057.89% | Liana Moussatos77% | → $33 | Initiates | → Outperform | Get Alert |
| 09/05/2018 | LQDA | Buy Now | Liquidia | $13.41 | 93.89% | Liana Moussatos77% | → $26 | Initiates | → Outperform | Get Alert |
| 08/06/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | 89.04% | Liana Moussatos77% | $115 → $120 | Maintains | Outperform | Get Alert |
| 08/06/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | Liana Moussatos77% | $70 → $73 | Maintains | Outperform | Get Alert |
| 08/06/2018 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 214.81% | Liana Moussatos77% | $80 → $85 | Maintains | Outperform | Get Alert |
| 08/06/2018 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | $203 → $217 | Maintains | Outperform | Get Alert |
| 08/02/2018 | UTHR | Buy Now | United Therapeutics | $300.76 | -15.88% | Liana Moussatos77% | $234 → $253 | Maintains | Outperform | Get Alert |
| 07/10/2018 | RGLS | Buy Now | Regulus Therapeutics | $3.36 | — | Liana Moussatos77% | — | Downgrade | Outperform → Neutral | Get Alert |
| 05/29/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | 81.16% | Liana Moussatos77% | $112 → $115 | Maintains | Outperform | Get Alert |
| 04/17/2018 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | $256 → $203 | Maintains | Outperform | Get Alert |
| 04/16/2018 | LXRX | Buy Now | Lexicon Pharmaceuticals | $0.67 | 5889.82% | Liana Moussatos77% | $38 → $40 | Maintains | Outperform | Get Alert |
| 03/27/2018 | VRNA | Buy Now | Verona Pharma | $73.58 | -25.25% | Liana Moussatos77% | $48 → $55 | Maintains | Outperform | Get Alert |
| 03/20/2018 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Liana Moussatos77% | $300 → $360 | Maintains | Outperform | Get Alert |
| 12/14/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $63.48 | — | Liana Moussatos77% | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/27/2017 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Liana Moussatos77% | → $30 | Initiates | → Outperform | Get Alert |
| 09/05/2017 | XOMA | Buy Now | XOMA | $24.38 | — | Liana Moussatos77% | — | Upgrade | Neutral → Outperform | Get Alert |
| 06/30/2017 | ALBO | Buy Now | Albireo Pharma | — | — | Liana Moussatos77% | → $58 | Initiates | → Outperform | Get Alert |
| 05/22/2017 | VRNA | Buy Now | Verona Pharma | $73.58 | -66.02% | Liana Moussatos77% | → $25 | Initiates | → Outperform | Get Alert |
| 03/29/2017 | RGLS | Buy Now | Regulus Therapeutics | $3.36 | 78.57% | Liana Moussatos77% | → $720 | Reiterates | → Outperform | Get Alert |
| 03/27/2017 | XOMA | Buy Now | XOMA | $24.38 | -63.08% | Liana Moussatos77% | $14 → $9 | Reiterates | → Neutral | Get Alert |
| 03/24/2017 | ASND | Buy Now | Ascendis Pharma | $166.00 | -79.52% | Liana Moussatos77% | $31 → $34 | Reiterates | → Outperform | Get Alert |
| 03/22/2017 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 229.63% | Liana Moussatos77% | → $89 | Reiterates | → Outperform | Get Alert |
| 03/06/2017 | RGLS | Buy Now | Regulus Therapeutics | $3.36 | 78.57% | Liana Moussatos77% | $960 → $720 | Reiterates | → Outperform | Get Alert |
| 01/30/2017 | RGLS | Buy Now | Regulus Therapeutics | $3.36 | 138.1% | Liana Moussatos77% | $1560 → $960 | Maintains | Outperform | Get Alert |
| 11/14/2016 | XOMA | Buy Now | XOMA | $24.38 | — | Liana Moussatos77% | — | Downgrade | Outperform → Neutral | Get Alert |
| 09/26/2016 | ASND | Buy Now | Ascendis Pharma | $166.00 | -79.52% | Liana Moussatos77% | → $34 | Initiates | → Outperform | Get Alert |
| 06/27/2016 | CLSD | Buy Now | Clearside Biomedical | $0.85 | 3201.89% | Liana Moussatos77% | → $28 | Initiates | → Outperform | Get Alert |
| 06/02/2016 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | Liana Moussatos77% | — | Initiates | → Outperform | Get Alert |
| 03/01/2016 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Liana Moussatos77% | → $42 | Initiates | → Outperform | Get Alert |
| 12/16/2015 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 355.56% | Liana Moussatos77% | $113 → $123 | Maintains | Outperform | Get Alert |
| 08/19/2015 | UTHR | Buy Now | United Therapeutics | $300.76 | -18.87% | Liana Moussatos77% | $209 → $244 | Maintains | Outperform | Get Alert |
| 08/03/2015 | LXRX | Buy Now | Lexicon Pharmaceuticals | $0.67 | 2745.16% | Liana Moussatos77% | $17 → $19 | Maintains | Outperform | Get Alert |
| 07/20/2015 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Liana Moussatos77% | → $1620 | Initiates | → Outperform | Get Alert |
| 08/29/2014 | UTHR | Buy Now | United Therapeutics | $300.76 | -53.12% | Liana Moussatos77% | $133 → $141 | Maintains | Outperform | Get Alert |
| 04/15/2013 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | $46 → $56 | Maintains | Outperform | Get Alert |
| 03/07/2013 | PCRX | Buy Now | Pacira BioSciences | $27.00 | 18.52% | Liana Moussatos77% | $23 → $32 | Maintains | Outperform | Get Alert |
| 01/07/2013 | XOMA | Buy Now | XOMA | $24.38 | -79.49% | Liana Moussatos77% | $80 → $100 | Maintains | Outperform | Get Alert |
| 11/29/2012 | RGLS | Buy Now | Regulus Therapeutics | $3.36 | 197.62% | Liana Moussatos77% | → $1200 | Initiates | → Outperform | Get Alert |
| 11/08/2012 | ICPT | Buy Now | Intercept Pharma | — | — | Liana Moussatos77% | → $25 | Initiates | → Outperform | Get Alert |
| 09/26/2012 | PCRX | Buy Now | Pacira BioSciences | $27.00 | — | Liana Moussatos77% | — | — | — | Get Alert |
| 09/11/2012 | PCRX | Buy Now | Pacira BioSciences | $27.00 | -14.81% | Liana Moussatos77% | $18 → $23 | Maintains | Outperform | Get Alert |
| 04/23/2012 | PCRX | Buy Now | Pacira Pharamaceuticals | $27.00 | -44.44% | Liana Moussatos77% | $18 → $15 | Maintains | Outperform | Get Alert |
| 04/09/2012 | PCRX | Buy Now | Pacira Pharamaceuticals | $27.00 | -33.33% | Liana Moussatos77% | $16 → $18 | Maintains | Outperform | Get Alert |
